Cargando…

The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature

BACKGROUND: Lipodystrophy syndromes are rare disorders of variable body fat loss associated with potentially serious metabolic complications. Familial partial lipodystrophy (FPLD) is mostly inherited as an autosomal dominant disorder. Renal involvement has only been reported in a limited number of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ru-Xuan, Zhang, Lei, Ye, Wei, Wen, Yu-Bing, Si, Nuo, Li, Hang, Li, Ming-Xi, Li, Xue-Mei, Zheng, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946515/ https://www.ncbi.nlm.nih.gov/pubmed/29747582 http://dx.doi.org/10.1186/s12882-018-0913-6

Ejemplares similares

Familial Partial Lipodystrophy: A Case Study and Review of Recent Literature
por: Tipu, Ali, et al.
Publicado: (2021)

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Evaluation of epicardial adipose tissue in familial partial lipodystrophy
por: Godoy-Matos, Amélio Fernando, et al.
Publicado: (2015)

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
por: Agarwal, Shubham, et al.
Publicado: (2023)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2022)

Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012)

Cardiac Manifestations of Congenital Generalized Lipodystrophy
por: Sanon, Vani P., et al.
Publicado: (2016)

Targeted Therapeutic Approach in Patients With Familial Partial Lipodystrophy Type 3
por: Cohen, Benjamin, et al.
Publicado: (2021)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation
por: Fountas, Athanasios, et al.
Publicado: (2017)

An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease
por: Panikkath, Ragesh, et al.
Publicado: (2016)

Novel Heterozygous LMNA Variants Causing Familial Partial Lipodystrophy, Dunnigan Variety
por: Wadhwa, Akhilesh, et al.
Publicado: (2021)

PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic
por: Iwanishi, Masanori, et al.
Publicado: (2018)

Evaluation of the hypothalamic–pituitary–adrenal axis in a case series of familial partial lipodystrophy
por: Elias, Cecília Pacheco, et al.
Publicado: (2019)

SUN-057 Familial Partial Lipodystrophy Presenting As Recurrent Acute Pancreatitis- Challenges In Management
por: Aljariri Alhesan, Nour, et al.
Publicado: (2019)

Massive labial lipomatous hypertrophy in familial partial lipodystrophy seen on computed tomographic angiography
por: Selting, Kevin, et al.
Publicado: (2019)

2287 ECG and echo characteristics in familial partial lipodystrophy: The impact of Lamin A variants
por: Eldin, Abdelwahab J., et al.
Publicado: (2018)

Challenges in Managing Metabolic Complications in a Patient With Familial Partial Lipodystrophy Type 3
por: Shah, Kajal, et al.
Publicado: (2021)

Metabolic Improvements After Gastric Sleeve Surgery in a Patient With Familial Partial Lipodystrophy
por: Niaz, Azra, et al.
Publicado: (2021)

SAT676 Severe Recurrent Pancreatitis In A Familial Partial Lipodystrophy Patient On Metreleptin
por: Sargin, Pinar, et al.
Publicado: (2023)

Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center
por: Kountouri, Aikaterini, et al.
Publicado: (2023)

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
por: Chiquette, Elaine, et al.
Publicado: (2017)

Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy–causing mutations
por: Simon, Dan N., et al.
Publicado: (2013)

Roux-en-Y Gastric Bypass Surgery in the Management of Familial Partial Lipodystrophy Type 1
por: Melvin, Audrey, et al.
Publicado: (2017)

Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy
por: Godoy-Matos, Amelio F., et al.
Publicado: (2018)

Rare Diagnosis of Familial Partial Lipodystrophy in a Patient With Life-Threatening Pancreatitis due to Hypertriglyceridemia
por: Akamnonu, Chukwuka, et al.
Publicado: (2021)

Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
por: Algieri, Cristina, et al.
Publicado: (2022)

Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
por: Fernandez-Pombo, Antia, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction
por: Schena, Elisa, et al.
Publicado: (2023)

SUN-LB111 Comparison of Phenotype and Metabolic Abnormalities Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2020)

Cardiac Alterations in Patients with Familial Lipodystrophy
por: Romano, Minna Moreira Dias, et al.
Publicado: (2020)

Familial Partial Lipodystrophy—Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3
por: Rutkowska, Lena, et al.
Publicado: (2022)

Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2
por: Corsa, Callie A.S., et al.
Publicado: (2021)

Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2
por: Valerio, Cynthia Melissa, et al.
Publicado: (2017)

Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient
por: Chen, Xi, et al.
Publicado: (2022)

Recurrent stroke as a presenting feature of acquired partial lipodystrophy
por: Prasad, Namburi R., et al.
Publicado: (2012)

Adult-Onset Acquired Partial Lipodystrophy Accompanied by Rheumatoid Arthritis
por: Muto, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_msq57bbqd51kn6egm93l1i7rkk